Variation of serum lipoproteins in postmyocardial infarction patients treated with verapamil or placebo
- PMID: 6587756
- DOI: 10.1111/j.0954-6820.1984.tb08678.x
Variation of serum lipoproteins in postmyocardial infarction patients treated with verapamil or placebo
Abstract
The effect of verapamil on plasma lipids and lipoproteins was studied in 64 patients taking part in a double blind controlled trial of verapamil versus placebo in post myocardial infarction. During a six month treatment period no significant difference was seen in plasma cholesterol, triglycerides, high density lipoproteins or low density lipoproteins.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical